| Description |
The pharmaceutical market has rapidly expanded over the past years to become truly global including the R&D sector. An increasing trend is to use so-called emerging markets where clinical trials can cost substantially less than those in Western countries.
China is at the forefront of this trend. The country has a well established tradition of developing medicines from basic research and the demand for modern pharmaceuticals is growing. Foreign companies are now realizing that these factors are of direct benefit for the conduct of clinical trials as they seek to alleviate the escalating time and costs of drug development.
However, the decision to outsource clinical trials to China requires an understanding of the scientific and regulatory changes in China and knowledge of Chinese culture in order to establish strong business relationships to ensure that patients, investigators and research staff carry out clinical trials according to ICH and GCP.
The China Clinical Trials Outsourcing Congress will address the major issues involved with commencing clinical trials in China. Some of the topics under discussion will be:
Incorporating China into your clinical trial strategy
Strategic and Regulatory considerations before conducting clinical trials in China
Considerations involved in designing the China component of the trial to position the drug for eventual China market approval
Assessing the real value of incorporating China into a multinational clinical trial strategy
The China SFDA has been working more closely with regulatory bodies and global industry leaders to improve its processes and approval times. Is this still an obstacle and will it bring about change in the near future?
What are the concerns for small pharma and biotech companies conducting clinical trials in China without operations in the country?
What are the issues and concerns involved with understanding Chinese culture?
Effectively managing the supply process for outsourced clinical trials
Case study of how one leading pharmaceutical company made the decision to outsource their clinical trials to China and what problems had to be faced and overcome
Case studies of successful collaboration between sponsor companies and contract research organisations in China.
There will be presentations from the world’s leading pharmaceutical and biotech companies as well as from China’s clinical trials experts and CROs.
Conference agenda
The conference agenda will be posted shortly - please enquire if you would like to join our panel of speakers.
Who will attend?
The China Clinical Trials Outsourcing Congress will attract senior level representatives from within the industry including Directors of Clinical R&D, Vice Presidents and Heads of Clinical Operations, R&D Directors , Head of Clinical Development in Asia, Heads of Clinical Operation, Senior Vice President and Vice Presidents of Global Clinical Trials,
Senior Director and Directors of Clinical Development, Director of Business Development, Heads of Regulatory Affairs, Clinical research managers.
Call for papers
If you would like to give a presentation or put forward a case study for the congress please contact Steve Hambrook, Conference Director, as below.
Delegates
Delegates will be able to exchange ideas and their experiences though panel discussions, case studies and networking opportunities. You will be able to take part in prearranged one-to-one meetings with solution providers from China to form partnerships and collaborations.
Solution Providers
Solution Providers will be able to raise their profile through sponsorship and exhibition opportunities gaining maximum exposure for their company including extensive pre and post event branding and marketing. All solution providers will feature on the event website with a hyperlink to their own company website.
You will also be able to take part in targeted one-on-one business meetings with selected delegates of your choice. You can choose your meetings from our list of delegates including names, job titles, companies and profiles and interests and will be given your meetings itinerary one week before the congress.
|
|
